Preexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable long-term outcomes after coronary artery bypass grafting

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Perek, Bartlomiej ^a   Malinska, Agnieszka ^a   Misterski, Marcin ^a   Ostalska Nowicka, Danuta ^a   Zabel, Maciej ^a   Perek, Anna ^a   Nowicki, Michal ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SAPHENOUS VEIN; TUNICA MEDIA; UPREGULATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SMOOTH MUSCLE FIBER; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY BYPASS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; SAPHENOUS VEIN; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TREATMENT OUTCOME; TUNICA MEDIA;

EID: 84885610498     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/730721     Document Type: Article

References (33)

1. Lopes R. D., Hafley G. E., Allen K. B., Ferguson T. B., Peterson E. D., Harrington R. A., Mehta R. H., Gibson C. M., Mack M. J., Kouchoukos N. T., Califf R. M., Alexander J. H., Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. The New England Journal of Medicine 2009 361 3 235 244 2-s2.0-67650909125 10.1056/NEJMoa0900708
2. Klinkert P., Post P. N., Breslau P. J., van Bockel J. H., Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. European Journal of Vascular and Endovascular Surgery 2004 27 4 357 362 2-s2.0-1642310221 10.1016/j.ejvs.2003.12.027 (Pubitemid 38386920)
3. Pfeiffer T., Reiher L., Grabitz K., Grünhage B., Häfele S., Voiculescu A., Fürst G., Sandmann W., Stanley J. C., Reconstruction for renal artery aneurysm: operative techniques and long-term results. Journal of Vascular Surgery 2003 37 2 293 300 2-s2.0-0037328621 10.1067/mva.2003.117 (Pubitemid 36236905)
4. Friedman J. A., Piepgras D. G., Current neurosurgical indications for saphenous vein graft bypass. Neurosurgical Focus 2003 14 3 e1 e3 2-s2.0-33645946715
5. Motwani J. G., Topol E. J., Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998 97 9 916 931 2-s2.0-0032502337 (Pubitemid 28113931)
6. Muto A., Model L., Ziegler K., Eghbalieh S. D. D., Dardik A., Mechanisms of vein graft adaptation to the arterial circulation-insights into the neointimal algorithm and management strategies. Circulation Journal 2010 74 8 1501 1512 2-s2.0-77955071887 10.1253/circj.CJ-10-0495
7. Schwartz R. S., Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. American Journal of Cardiology 1998 81 7 14E 17E 2-s2.0-0032499146 10.1016/S0002-9149(98)00191-X (Pubitemid 28182623)
8. Domanski M. J., Borkowf C. B., Campeau L., Knatterud G. L., White C., Hoogwerf B., Rosenberg Y., Geller N. L., Prognostic factors for atherosclerosis progression in saphenous vein grafts: The Postcoronary Artery Bypass Graft (Post-CABG) Trial. Journal of the American College of Cardiology 2000 36 6 1877 1883 2-s2.0-0034669459 10.1016/S0735-1097(00)00973-6
9. Hassantash S.-A., Bikdeli B., Kalantarian S., Sadeghian M., Afhar H., Pathophysiology of aortocoronary saphenous vein bypass graft disease. Asian Cardiovascular and Thoracic Annals 2008 16 4 331 336 2-s2.0-52649173954
10. Mitra A. K., Gangahar D. M., Agrawal D. K., Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunology & Cell Biology 2006 84 2 115 124 2-s2.0-33644745116 10.1111/j.1440-1711.2005.01407.x (Pubitemid 43344665)
11. Johnson J. L., van Eys G. J. J. M., Angelini G. D., George S. J., Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 7 1146 1151 2-s2.0-0035721934 (Pubitemid 34215142)
12. Turner N. A., Hall K. T., Ball S. G., Porter K. E., Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis 2007 193 1 36 43 2-s2.0-34248665545 10.1016/j.atherosclerosis.2006.08.017 (Pubitemid 46776708)
13. Crowther M., Goodall S., Jones J. L., Bell P. R. F., Thompson M. M., Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. Journal of Vascular Surgery 2000 32 3 575 583 2-s2.0-0033831295 10.1067/mva.2000.108010
14. Raffetto J. D., Khalil R. A., Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochemical Pharmacology 2008 75 2 346 359 2-s2.0-37349082926 10.1016/j.bcp.2007.07.004 (Pubitemid 350298459)
15. Johnson J. L., Baker A. H., Oka K., Chan L., Newby A. C., Jackson C. L., George S. J., Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis. Circulation 2006 113 20 2435 2444 2-s2.0-33744485260 10.1161/CIRCULATIONAHA.106.613281 (Pubitemid 43948051)
16. Murphy G., Tissue inhibitors of metalloproteinases. Genome Biology 2011 12 11, article 233 2-s2.0-81255188391 10.1186/gb-2011-12-11-233
17. Aravind B., Saunders B., Navin T., Sandison A., Monaco C., Paleolog E. M., Davies A. H., Inhibitory effect of TIMP influences the morphology of varicose veins. European Journal of Vascular and Endovascular Surgery 2010 40 6 754 765 2-s2.0-78649629120 10.1016/j.ejvs.2010.04.028
18. Goldman S., Zadina K., Moritz T., Ovitt T., Sethi G., Copeland J. G., Thottapurathu L., Krasnicka B., Ellis N., Anderson R. J., Henderson W., Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. Journal of the American College of Cardiology 2004 44 11 2149 2156 2-s2.0-9644291513 10.1016/j.jacc.2004.08.064 (Pubitemid 39576034)
19. Epstein A. J., Polsky D., Yang F., Yang L., Groeneveld P. W., Coronary revascularization trends in the united states, 2001-2008. The Journal of the American Medical Association 2011 305 17 1769 1776 2-s2.0-79955624770 10.1001/jama.2011.551
20. FitzGibbon G. M., Kafka H. P., Leach A. J., Keon W. J., Hooper G. D., Burton J. R., Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. Journal of the American College of Cardiology 1996 28 3 616 626 2-s2.0-0030245599 10.1016/S0735-1097(96)00206-9 (Pubitemid 26288642)
21. Gault M. H., Longerich L. L., Harnett J. D., Wesolowski C., Predicting glomerular function from adjusted serum creatinine. Nephron 1992 62 3 249 256 2-s2.0-0026781518
22. Remmele W., Stegner H. E., Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987 8 3 138 140 2-s2.0-0023340925
23. Perek B., Malinska A., Nowicki M., Histological evaluation of age-related variations in saphenous vein grafts used for coronary artery bypass grafting. Archieves of Medical Sciences 2012 8 6 1041 1047
24. Flaherty J. D., Davidson C. J., Diabetes and coronary revascularization. The Journal of the American Medical Association 2005 293 12 1501 1508 2-s2.0-15044357561 10.1001/jama.293.12.1501 (Pubitemid 40393296)
25. Endo M., Tomizawa Y., Nishida H., Bilateral versus unilateral internal mammary revascularization in patients with diabetes. Circulation 2003 108 11 1343 1349 2-s2.0-0141542683 10.1161/01.CIR.0000085995.87982.6E (Pubitemid 37174412)
26. George S. J., Zaltsman A. B., Newby A. C., Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. Cardiovascular Research 1997 33 2 447 459 2-s2.0-0031015779 10.1016/S0008-6363(96)00211-8 (Pubitemid 27072650)
27. Yongxin S., Wenjun D., Qiang W., Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits. The Annals of Thoracic Surgery 2013 95 1 55 62
28. Southgate K. M., Mehta D., Izzat M. B., Newby A. C., Angelini G. D., Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 7 1640 1649 2-s2.0-0033001718 (Pubitemid 29323822)
29. Galis Z. S., Khatri J. J., Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circulation Research 2002 90 3 251 262 2-s2.0-0037155057 (Pubitemid 34633925)
30. Pyo R., Lee J. K., Shipley J. M., Curci J. A., Mao D., Ziporin S. J., Ennis T. L., Shapiro S. D., Senior R. M., Thompson R. W., Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. Journal of Clinical Investigation 2000 105 11 1641 1649 2-s2.0-0034090148 (Pubitemid 30390315)
31. Tayebjee M. H., Karalis I., Nadar S. K., Beevers D. G., MacFadyen R. J., Lip G. Y. H., Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. American Journal of Hypertension 2005 18 3 325 329 2-s2.0-15744377634 10.1016/j.amjhyper.2004. 09.014 (Pubitemid 40409911)
32. Chung A. W., Booth A. D., Rose C., Thompson C. R., Levin A., Van Breemen C., Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction. Journal of Vascular Research 2008 45 4 357 362 2-s2.0-44849099266 10.1159/000119755 (Pubitemid 351793739)
33. Spiers J. P., Kelso E. J., Siah W. F., Edge G., Song G., McDermott B. J., Hennessy M., Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade. Journal of Hypertension 2005 23 9 1717 1724 2-s2.0-24144442656 (Pubitemid 41233432)